Taken together, our results revealed that Nos2 overexpression disrupts the intracellular antimicrobial and anti-inflammatory environment by increasing the concentration of NO, decreasing the levels of ROS and Defb1, and resulting in the enhancement of MS pulmonary colonization capacity in mice. This evidence concerns the gene NOS2 and myeloid sarcoma.